Cutler Group LP Revance Therapeutics, Inc. Put Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 07, 2023	SELL	$18.32 - $30.66 $5,496 - $9,198	-300 Reduced 27.27%	800 $0
Q2 2022 Aug 04, 2022	SELL	$11.52 - $20.4 $31,104 - $55,079	-2,700 Reduced 71.05%	1,100 $5,000
Q1 2022 Apr 14, 2022	BUY	$12.36 - $20.31 $32,136 - $52,806	2,600 Added 216.67%	3,800 $5,000
Q4 2021 Jan 18, 2022	SELL	$12.46 - $27.87 $9,968 - $22,296	-800 Reduced 40.0%	1,200 $1,000
Q1 2018 May 11, 2018	BUY	$29.15 - $37.4 $58,300 - $74,800	2,000 New	2,000 $12,000

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.